|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/11 |
| (11) | Patento numeris | 2225376 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08857617.8 |
| Europos patento paraiškos padavimo data | 2008-11-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-01-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/DK2008/000418 |
| Data | 2008-11-26 |
| (87) | Numeris | WO 2009/071082 |
| Data | 2009-06-11 |
| (30) | Numeris | Data | Šalis |
| 992050 P | 2007-12-03 | US |
| (72) |
HEDT JÅRN, Maj, DK
|
| (73) |
Santaris Pharma A/S,
Fremtidsvej 3, 2970 H rsholm,
DK
|
| (54) | RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF PIK3CA EXPRESSION |
| RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF PIK3CA EXPRESSION |